Health Condition 1: F068- Other specified mental disorders due to known physiological condition Health Condition 2: F09- Unspecified mental disorder due toknown physiological condition
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
SRIHER DU
Eligibility
Inclusion criteria
Inclusion criteria: Patients attending the outpatient clinic aged 18 years to 50 years and either gender. Patients diagnosed with depression as per Diagnostic and Statistical Manual V(DSM V ) criteria by physician
Exclusion criteria
Exclusion criteria: Pregnant or breast feeding women. Patients with previous history of hypersensitivity to SSRI and had serotonin syndrome. Patients with severe depression requiring inpatient admission. Suicidal behaviour within 30 days before screening.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of Vortioxetine in comparison to Fluoxetine on metabolic parameters in depressive disorder by using International Diabetes Federation Scale (IDFS) To assess the quality of life using Rand SF-36 QuestionnaireTimepoint: After taking baseline the drug therapy is assessed on 4th week, 8th week and 12th week | — |
Secondary
| Measure | Time frame |
|---|---|
| To screen the possible risk for Vortioxetine and Fluoxetine during the study periodTimepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr.A. Mohathasim Billah
SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH(DU)
Outcome results
None listed